TY - JOUR
T1 - Bringing an end to diabetes stigma and discrimination
T2 - an international consensus statement on evidence and recommendations
AU - Speight, Jane
AU - Holmes-Truscott, Elizabeth
AU - Garza, Matthew
AU - Scibilia, Renza
AU - Wagner, Sabina
AU - Kato, Asuka
AU - Pedrero, Victor
AU - Deschênes, Sonya
AU - Guzman, Susan J.
AU - Joiner, Kevin L.
AU - Liu, Shengxin
AU - Willaing, Ingrid
AU - Babbott, Katie M.
AU - Cleal, Bryan
AU - Dickinson, Jane K.
AU - Halliday, Jennifer A.
AU - Morrissey, Eimear C.
AU - Nefs, Giesje
AU - O'Donnell, Shane
AU - Serlachius, Anna
AU - Winterdijk, Per
AU - Alzubaidi, Hamzah
AU - Arifin, Bustanul
AU - Cambron-Kopco, Liz
AU - Santa Ana, Corinna
AU - Davidsen, Emma
AU - de Groot, Mary
AU - de Wit, Maartje
AU - Deroze, Phyllisa
AU - Haack, Stephanie
AU - Holt, Richard I.G.
AU - Jensen, Walther
AU - Khunti, Kamlesh
AU - Kragelund Nielsen, Karoline
AU - Lathia, Tejal
AU - Lee, Christopher J.
AU - McNulty, Bridget
AU - Naranjo, Diana
AU - Pearl, Rebecca L.
AU - Prinjha, Suman
AU - Puhl, Rebecca M.
AU - Sabidi, Anita
AU - Selvan, Chitra
AU - Sethi, Jazz
AU - Seyam, Mohammed
AU - Sturt, Jackie
AU - Subramaniam, Mythily
AU - Terkildsen Maindal, Helle
AU - Valentine, Virginia
AU - Vallis, Michael
AU - Skinner, Timothy C.
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/1
Y1 - 2024/1
N2 - People with diabetes often encounter stigma (ie, negative social judgments, stereotypes, prejudice), which can adversely affect emotional, mental, and physical health; self-care, access to optimal health care; and social and professional opportunities. To accelerate an end to diabetes stigma and discrimination, an international multidisciplinary expert panel (n=51 members, from 18 countries) conducted rapid reviews and participated in a three-round Delphi survey process. We achieved consensus on 25 statements of evidence and 24 statements of recommendations. The consensus is that diabetes stigma is driven primarily by blame, perceptions of burden or sickness, invisibility, and fear or disgust. On average, four in five adults with diabetes experience diabetes stigma and one in five experience discrimination (ie, unfair and prejudicial treatment) due to diabetes, such as in health care, education, and employment. Diabetes stigma and discrimination are harmful, unacceptable, unethical, and counterproductive. Collective leadership is needed to proactively challenge, and bring an end to, diabetes stigma and discrimination. Consequently, we achieved unanimous consensus on a pledge to end diabetes stigma and discrimination.
AB - People with diabetes often encounter stigma (ie, negative social judgments, stereotypes, prejudice), which can adversely affect emotional, mental, and physical health; self-care, access to optimal health care; and social and professional opportunities. To accelerate an end to diabetes stigma and discrimination, an international multidisciplinary expert panel (n=51 members, from 18 countries) conducted rapid reviews and participated in a three-round Delphi survey process. We achieved consensus on 25 statements of evidence and 24 statements of recommendations. The consensus is that diabetes stigma is driven primarily by blame, perceptions of burden or sickness, invisibility, and fear or disgust. On average, four in five adults with diabetes experience diabetes stigma and one in five experience discrimination (ie, unfair and prejudicial treatment) due to diabetes, such as in health care, education, and employment. Diabetes stigma and discrimination are harmful, unacceptable, unethical, and counterproductive. Collective leadership is needed to proactively challenge, and bring an end to, diabetes stigma and discrimination. Consequently, we achieved unanimous consensus on a pledge to end diabetes stigma and discrimination.
UR - http://www.scopus.com/inward/record.url?scp=85180567962&partnerID=8YFLogxK
U2 - 10.1016/S2213-8587(23)00347-9
DO - 10.1016/S2213-8587(23)00347-9
M3 - Review article
C2 - 38128969
AN - SCOPUS:85180567962
SN - 2213-8587
VL - 12
SP - 61
EP - 82
JO - The Lancet Diabetes and Endocrinology
JF - The Lancet Diabetes and Endocrinology
IS - 1
ER -